Prognostic value of platelet-to-lymphocyte ratio in neoadjuvant chemotherapy for solid tumors: A PRISMA-compliant meta-analysis

INTRODUCTION: Previous research indicates that the platelet-to-lymphocyte ratio (PLR) may be an indicator of poor prognosis in many tumor types. However, the PLR is rarely described in patients undergoing neoadjuvant chemotherapy (NAC) for solid tumors. Thus, we performed a meta-analysis to investig...

Descripción completa

Detalles Bibliográficos
Autores principales: Long, Yuming, Zhang, Yingtian, Ni, Liwei, Yuan, Xuya, Liu, Yuanliang, Tao, Jialong, Zhang, Yusong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
5700
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8294933/
https://www.ncbi.nlm.nih.gov/pubmed/34397999
http://dx.doi.org/10.1097/MD.0000000000026202

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8294933/
https://www.ncbi.nlm.nih.gov/pubmed/34397999
http://dx.doi.org/10.1097/MD.0000000000026202

Ejemplares similares